Suchergebnisse - (Person:"Jia, Zhejun")

PubPharm (14)

1

BISPECIFIC ANTIBODIES AND USES THEREOF

enthalten in: Europäisches Patentamt | 2023

von LIU YUE | CAI WENYAN | SHI JIADONG | +1

2

BISPECIFIC ANTIBODIES AND USES THEREOF

enthalten in: Europäisches Patentamt | 2023

von LIU YUE | CAI WENYAN | SHI JIADONG | +1

3

BISPECIFIC ANTIBODIES AND USES THEREOF

enthalten in: Europäisches Patentamt | 2022

von LIU YUE | CAI WENYAN | SHI JIADONG | +1

4

BISPECIFIC ANTIBODIES AND USES THEREOF

enthalten in: Europäisches Patentamt | 2022

von LIU YUE | CAI WENYAN | SHI JIADONG | +1

5

BISPECIFIC ANTIBODIES AND USES THEREOF

enthalten in: Europäisches Patentamt | 2021

von LIU YUE | CAI WENYAN | SHI JIADONG | +1

6

Biological activity validation of a computationally designed Rituximab/CD3 T cell engager targeting CD20+ cancers with multiple mechanisms of action

enthalten in: Antibody therapeutics | 2021

von Cai, W. | Dong, J. | Gallolu Kankanamalage, S. | +11

7

Author Correction : Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2

enthalten in: Scientific reports | 2021

von Dong, J. | Huang, B. | Wang, B. | +6

ErratumFor: Sci Rep. 2020 Oct 20;10(1):17806. - PMID 33082473

8

Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity

enthalten in: Emerging microbes & infections | 2020

von Dong, J. | Huang, B. | Jia, Z. | +4

9

Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2

enthalten in: Scientific reports | 2020

von Dong, J. | Huang, B. | Wang, B. | +6

ErratumIn: Sci Rep. 2021 Feb 17;11(1):4371. - PMID 33597581

10

BISPECIFIC ANTIBODIES AND USES THEREOF

enthalten in: Europäisches Patentamt | 2020

von LIU YUE | CAI WENYAN | SHI JIADONG | +1